MDT

Medtronic plc. Ordinary Shares (MDT)

Stock · NYSE · Health Care

$91.23as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 30, 2026

Medtronic Draws Analyst Upgrades Ahead Of Earnings Call. Two separate brokerages, TD Cowen and Needham, have raised their price targets on Medtronic ahead of the company's upcoming earnings call. The increases signal that analysts are updating their expectations based on newer information heading into the report. The commentary also surfaced in coverage of large recent trades in health care stocks, suggesting notable investor interest in the sector. Medtronic's results, due shortly, will likely be the next key catalyst for the stock.

Active signals

Support level
$85.84
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, an…

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Employees
95,000

Fundamentals

1-day range
$90.05$91.54
Market cap
$110.95B
P/E (trailing)
24.25
P/E (forward)
14.24
EPS (trailing)
$3.73
Dividend yield
3.50%
Beta
0.57
Avg. volume
8.64M
Ex-dividend date
September 25, 2026
Dividend pay date
October 16, 2026
52-week range
$73.31$106.33
Next earnings: September 1, 2026 · EPS estimate $1.39Before Openconfirmed

How Medtronic plc. Ordinary Shares Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$33.54BNet Income$4.66B (14%)Cost of Revenue$11.63B (35%)SG&A$10.85B (32%)Other$5.46B (16%)Tax$936.00M (3%)MDT

Source: 10-K filed Jun 20, 2025 · via SEC EDGAR / Finnhub

Forecasts

25 analyst ratings

Buy 65%
Hold 35%
Sell 0%
1-year price forecast
High
$121
+32.6%
Median
$100
+9.6%
Low
$78
-14.5%

Medtronic plc. Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • MDT
    Medtronic plc. Ordinary Shares
    $91.2
    ▲ 1.37%
    Market cap $110.95BP/E 24.25
    $73.31$106.33
  • LIVN
    LivaNova PLC Ordinary Shares
    $80.34
    ▲ 0.39%
    Market cap $4.53BP/E 23.84
    $48.82$85.76
  • PRKS
    United Parks & Resorts Inc. Common Stock
    $42.48
    ▼ 0.02%
    Market cap $2.18BP/E 15.29
    $28.77$56.95
  • BLFS
    BioLife Solutions Inc. Common Stock
    $36.4
    ▼ 2.15%
    Market cap $1.57BP/E 29.72
    $17.86$38.1
  • CNMD
    CONMED Corporation Common Stock
    $49.98
    ▼ 0.68%
    Market cap $1.55BP/E 26.36
    $31.44$56.64
  • CV
    CapsoVision Inc. Common Stock
    $5.95
    ▼ 1.82%
    Market cap $358.24MP/E
    $3.43$15.37
  • ELMD
    Electromed Inc. Common Stock
    $29.65
    ▼ 1.63%
    Market cap $344.29MP/E 34.86
    $23.01$47.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
412.0K
Disposed
1.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.